TY - JOUR
T1 - Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF- prolylhydroxylase
AU - Selak, M.A.
AU - Armour, S.M.
AU - MacKenzie, E.D.
AU - Boulahbel, H.
AU - Watson, D.G.
AU - Mansfield, K.D.
AU - Pan, Y.
AU - Simon, M.C.
AU - Thompson, C.B.
AU - Gottlieb, E.
PY - 2005
Y1 - 2005
N2 - Several mitochondrial proteins are tumor suppressors. These include succinate dehydrogenase (SDH) and fumarate hydratase, both enzymes of the tricarboxylic acid (TCA) cycle. However, to date, the mechanisms by which defects in the TCA cycle contribute to tumor formation have not been elucidated. Here we describe a mitochondrion-to-cytosol signaling pathway that links mitochondrial dysfunction to oncogenic events: succinate, which accumulates as a result of SDH inhibition, inhibits HIF-α prolyl hydroxylases in the cytosol, leading to stabilization and activation of HIF-1α. These results suggest a mechanistic link between SDH mutations and HIF-1α induction, providing an explanation for the highly vascular tumors that develop in the absence of VHL mutations.
AB - Several mitochondrial proteins are tumor suppressors. These include succinate dehydrogenase (SDH) and fumarate hydratase, both enzymes of the tricarboxylic acid (TCA) cycle. However, to date, the mechanisms by which defects in the TCA cycle contribute to tumor formation have not been elucidated. Here we describe a mitochondrion-to-cytosol signaling pathway that links mitochondrial dysfunction to oncogenic events: succinate, which accumulates as a result of SDH inhibition, inhibits HIF-α prolyl hydroxylases in the cytosol, leading to stabilization and activation of HIF-1α. These results suggest a mechanistic link between SDH mutations and HIF-1α induction, providing an explanation for the highly vascular tumors that develop in the absence of VHL mutations.
KW - tricarboxylic acid (TCA) cycle
KW - succinate dehydrogenase (SDH)
KW - prolylhydroxylase
UR - http://dx.doi.org/10.1016/j.ccr.2004.11.022
U2 - 10.1016/j.ccr.2004.11.022
DO - 10.1016/j.ccr.2004.11.022
M3 - Article
SN - 1535-6108
VL - 7
SP - 77
EP - 85
JO - Cancer Cell
JF - Cancer Cell
ER -